RT Conference Proceedings
T1 Activated protein C, severe sepsis and 28-day mortality.
A1 Torre-Prados, M de la
A1 García-de la Torre, A
A1 Nieto-González, M
A1 Lucena-González, I
A1 Escobar-Conesa, R
A1 García-Alcántara, A
A1 Enguix-Armada, A
K1 Deficiencia de Proteína C
K1 Coagulación Sanguínea
K1 Choque Séptico
K1 Proteina C
K1 Humanos
AB Protein C (PC) de  ciency is prevalent in severe sepsis, studies showing that more than 80% of patients with severe sepsishave a baseline PC level below the lower limit of normal [1,2]. The aim of the study was to relate the anticoagulation activity evaluated by PC, with clinical parameters and 28-day mortality.
PB BioMed Central
SN 1364-8535
YR 2012
FD 2012-05-20
LK http://hdl.handle.net/10668/866
UL http://hdl.handle.net/10668/866
LA en
NO Torre-Prados M de la., García-de la Torre A., Nieto-González M., Lucena-González I., Escobar-Conesa R., García-Alcántara A. et al. Activated protein C, severe sepsis and 28-day mortality. Critical Care. 2012;16(Suppl. 1):S8-S9
DS RISalud
RD Apr 10, 2025